A time-tested, scientifically grounded therapy to retrain the immune system for long-lasting relief.

Origin: Developed in the 1960s by Dr. Leonard McEwen, a pioneer in immunotherapy.
Primary Focus: Effectively treats allergies, food sensitivities, autoimmune conditions, and some chronic inflammatory disorders.
Mechanism: Utilizes extremely low doses of allergens mixed with beta-glucuronidase, a natural enzyme that acts as an immunological "key" to open the door to immune tolerance.
Goal: Restores immune tolerance by reprogramming the immune system, not just suppressing symptoms.
Administration: Delivered via intradermal injection or sublingual drops.
Formulations: Scientifically blended mixtures based on decades of clinical research, covering a wide range of common allergens.
Long-term studies: 10,500 patients

A newer, therapy built upon LDA principles.

Origin: Created by Dr. Ty Vincent around 2013.
Primary Focus: Used for a range of chronic conditions, including infections, mold illness, and neurological issues like autism spectrum disorders.
Mechanism: Uses diluted antigens (e.g., bacteria, viruses, foods) without an enzyme adjuvant, relying solely on dose calibration to reduce reactivity.
Goal: Seeks to promote tolerance through customized micro doses, often through a process of trial and error.
Administration: Delivered via sublingual drops.
Formulations: Tailored to each patient, offering flexibility but requiring more patient-specific testing and tracking.
Long-term studies: none